Is Biomind Labs Inc. (BMNDF) a Buy, Sell, or Hold?
OTC : BMNDF
Biomind Labs Inc.
$0.2499 USD
-$0.55 (-68.76%)
- Volume
- 2K
- Average Volume
- 3.21K
- Market Capitalization
- $19.39M
- P/E Ratio
- -21.73
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.80
- Year Low
- $0.01
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.01
Company Overview
OTC
Alejandro Antalich
Biotechnology
Healthcare
BMNDF
5
CA
USD
Liquidity Metrics
-0.43
0.01
0.01
0.01
0.00
Sales & Valuation
-$
0.00
-10.69
-144.45
0.00
Profitability
-$0.0111
-$865.3K
0.00%
0.00%
54.12%
-6212.83%
P/E Metrics
-21.73
-0.06
-0.06
Analyst Price Target & Rating
2/5
0 Analysts
%
Financial Health Scores
-1860.39
1/9
-$1.81M
$14387.0
$1.83M
-$820.53K
Key Metrics (TTM)
$62.83M
0.00
-76.57
0.01
54.12%
79.69%
-1.44%
-0.22%
0 days
Company Executives
| Name | Title |
|---|---|
| Juan Presa | Chief Legal Officer |
| Oscar Alejandro León Bentancor | Chief Financial Officer & Director |
| Paola Diaz Dellavalle | Chief Scientific Officer |
| Martin Daners | Head of Quality Assurance & Regulatory Affairs |
| Alejandro Antalich | Chief Executive Officer & Director |
Poll Results
No votes yet today — be the first to share your view!
About Biomind Labs Inc. (OTC:BMNDF) Stock
Biomind Labs Inc. operates as a biotechnology firm dedicated to advancing innovative pharmaceutical therapies and sophisticated nanotech drug delivery mechanisms, primarily addressing a range of psychiatric and neurological disorders. Among its leading pipeline assets, BMND01 is currently in Phase II clinical trials for treating depression. Another key candidate, BMND08, a derivative of 5-Methoxy-N,N-dimethyltryptamine, is also in Phase II trials, addressing depression and anxiety specifically in patients experiencing cognitive decline associated with Alzheimer's disease. The company's broader development portfolio includes early-stage and preclinical candidates such as BMND02 for fibromyalgia, BMND03 for substance use disorders, BMND05 for persistent pain management, BMND06 for inflammato ... ry conditions, and BMND07 for severe clinical depression. Biomind Labs Inc. maintains its headquarters in Canelones, Uruguay.
2026-08-06 16:15:00
VANCOUVER, BC / ACCESS Newswire / August 6, 2026 / Biomind Labs Inc. ("Biomind" or the "Company") (CBOE:BMND) (OTC PINK:BMNDF), a clinical-stage biopharmaceutical company focused on transforming breakthroughs in neuroscience and biomedical research into novel pharmaceutical drugs, is pleased to announce that it has received approval to list its common shares (the "Common Shares") on the Canadian Securities Exchange (the "CSE"), and the Common Shares will commence trading on the CSE at market open on August 11, 2026 under the symbol "BMND". In connection with the listing of the Common Shares on the CSE, the Company will be delisting its Common Shares from the Cboe Canada (the "Cboe") effective close of business on August 10, 2026.
Frequently Asked Questions
-
What is the current Biomind Labs Inc. (BMNDF) stock price?
-
Biomind Labs Inc.(OTC:BMNDF) stock price is $0.2499 in the last trading session. During the trading session, BMNDF stock reached the peak price of $0.8 while $0.011 was the lowest point it dropped to. The percentage change in BMNDF stock occurred in the recent session was --68.76% while the dollar amount for the price change in BMNDF stock was -$0.55.
-
BMNDF's industry and sector of operation?
-
The OTC listed BMNDF is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of BMNDF?
-
Juan Presa | Chief Legal Officer
Oscar Alejandro León Bentancor | Chief Financial Officer & Director
Paola Diaz Dellavalle | Chief Scientific Officer
Martin Daners | Head of Quality Assurance & Regulatory Affairs
Alejandro Antalich | Chief Executive Officer & Director -
How many employees does BMNDF have?
-
Number of BMNDF employees currently stands at 5. BMNDF operates from 701 West Georgia Street, Suite 515, Vancouver, BC V7Y 1C6, CA.
-
Link for BMNDF official website?
-
Official Website of BMNDF is: https://www.biomindlabs.com
-
How do I contact BMNDF?
-
BMNDF could be contacted at phone #+1 647 360 4055 and can also be accessed through its website. BMNDF operates from 701 West Georgia Street, Suite 515, Vancouver, BC V7Y 1C6, CA.
-
How many shares of BMNDF are traded daily?
-
The average number of BMNDF shares traded daily for last 3 months was 3.21K.
-
What is the market cap of BMNDF currently?
-
The market value of BMNDF currently stands at $19.39M with its latest stock price at $0.2499